• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium

    ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium

  2. Research and Markets: Global All-Electric Injection Molding Machine Industry Report 2014

    Research and Markets: Global All-Electric Injection Molding Machine Industry Report 2014

  3. Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association

    Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association

  4. Research and Markets: Global Seasonal Affective Disorder (SAD) Clinical Trials Therapeutics Review H2, 2014 Featuring GSK & 5 Top Institutes

    Research and Markets: Global Seasonal Affective Disorder (SAD) Clinical Trials Therapeutics Review H2, 2014 Featuring GSK & 5 Top Institutes

  5. Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization

    Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization

  6. Isis Pharmaceuticals to Present at Upcoming Investor Conferences

    Isis Pharmaceuticals to Present at Upcoming Investor Conferences

  7. AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods

    AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods

  8. LONDON MARKETS: FTSE Ends Higher After ECB Hints At Stimulus

    LONDON MARKETS: FTSE Ends Higher After ECB Hints At Stimulus

  9. The Progress Group Joins Global Supply Chain Consultancy, Crimson & Co

    The Progress Group Joins Global Supply Chain Consultancy, Crimson & Co

  10. GlaxoSmithKline Files Regulatory Submissions in U.S., Europe For Mepolizumab

    GlaxoSmithKline Files Regulatory Submissions in U.S., Europe For Mepolizumab

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.